期刊
STATISTICAL METHODS IN MEDICAL RESEARCH
卷 17, 期 5, 页码 515-518出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/0962280207081862
关键词
-
There has been interest in using progression-free survival as a surrogate endpoint for overall survival in oncology clinical trials. In order to objectively define this endpoint, clear understanding of what progression means, how it is measured and what its implications are need to be discussed. This article discusses some regulatory aspects of using progression-free survival as an endpoint.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据